Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276

株式のランク #544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
株価
$6.89
時価総額
$43.94B
変化(1日)
-2.91%
変化(1年)
-24.78%
国
CN
取引 Jiangsu Hengrui Medicine Co., Ltd. (600276)

カテゴリー

Healthcare
Jiangsu Hengrui Medicine Co., Ltd.(600276)の株式分割履歴
Jiangsu Hengrui Medicine Co., Ltd.株(シンボル:600276)は合計で19回の株式分割を実施しました。
最新の株式分割はJun 10, 2021に行われました。
May 11, 2001より前に購入された600276株は、現在47.810942329106600276株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2021-06-10 6:5 x1.2 x47.810942329106
2020-05-25 6:5 x1.2 x39.842451940921
2019-03-28 6:5 x1.2 x33.202043284101
2018-05-30 13:10 x1.3 x27.668369403418
2017-05-31 6:5 x1.2 x21.283361079552
2016-06-16 6:5 x1.2 x17.73613423296
2015-06-15 13:10 x1.3 x14.7801118608
2014-05-15 11:10 x1.1 x11.369316816
2013-06-07 11:10 x1.1 x10.33574256
2012-05-29 11:10 x1.1 x9.3961296
2011-04-26 3:2 x1.5 x8.541936
2010-03-17 6:5 x1.2 x5.694624
2009-04-30 6:5 x1.2 x4.74552
2008-04-11 6:5 x1.2 x3.9546
2007-04-02 13:10 x1.3 x3.2955
2006-08-29 13:10 x1.3 x2.535
2006-06-19 5:4 x1.25 x1.95
2002-05-21 6:5 x1.2 x1.56
2001-05-11 13:10 x1.3 x1.3
類似企業または競合他社の株式分割